Cited in boardrooms, legal proceedings & government briefings since 2017
Medical cannabis is legal in Czech Republic and adult-use is illegal. Below: a free market overview, with the full sizing, regulation and trade data available from PP.
Medical cannabis sales and registered patients in Czech Republic, 2025 actuals and the 2027 forecast. Forecasts to 2030 are in the Czech Republic data pack.
Medical sales, EUR
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| Medical sales | €5.2m | €6.6m | €8m | |||
| Patients | 11,983 | 15,095 | 18,384 |
Forecasts to 2030 — sales, patients and the full Czech Republic series — are in the Czech Republic data pack, or scoped to your question in a bespoke brief.
See the data pack Request a briefSource: Prohibition Partners — Global Medical Cannabis Market Review (2026, updated April 2026) & The European Cannabis Report (2025)
How Czech Republic’s framework got here, and what moves next.
Medical framework established
Act No. 50/2013 Coll. lets patients with specific conditions receive medical cannabis treatment.
GPs can prescribe for chronic pain
General practitioners gain prescribing rights for chronic-pain patients, easing access in one of Europe's most liberal drug-policy environments.
Growth from a liberal baseline
Sales and patient numbers keep growing; PP tracks the trajectory against peers in Market Intelligence.
From International Cannabis Weekly, our free global briefing.
expats.cz · №464 · 28 Aug 2026 · Hemp & CBD
Sechat · №455 · 26 Jun 2026 · Regulation
HempToday · №453 · 12 Jun 2026 · Hemp & CBD
expats.cz · №432 · 9 Jan 2026 · Regulation
Business of Cannabis · №422 · 17 Oct 2025 · Business & Investment
Newsweed · №418 · 19 Sept 2025 · Regulation
The Czech Republic’s estimated medical cannabis market size for 2025 is over €3.5 million.
The Czech Republic is one of the most liberal countries in Europe in terms of its medical cannabis and overall drug policy. The country first established its medical cannabis framework in 2013, allowing patients with specific conditions and illnesses to receive medical cannabis treatment. The Czech Republic is a small market compared to countries such as Germany, the UK and Poland, though sales and patient numbers are still growing. From April 2025, general practitioners have been able to prescribe medical cannabis to patients suffering from chronic pain, easing patient access and stimulating market growth.
As of 1 January 2022, an Amendment to the Addictive Substances Act came into force, which removed the tender for domestic cultivation, allowing companies to apply for a cultivation licence. This has resulted in a growing domestic cultivation industry.
The Czech Republic is currently still an import-reliant medical cannabis market, however, following the opening of the commercial cultivation market the country has become a strong cultivator of medical cannabis for European export. In 2024, the Czech Republic saw its first export of medical cannabis into Germany with the country exporting over 1,300 kilograms over the year to Germany.
In the full Czech Republic market data
Sizing, forecasts, pricing, trade flows and licensed operators — verified by PP’s analysts. Available as a data pack.